72
Participants
Start Date
November 6, 2017
Primary Completion Date
May 5, 2021
Study Completion Date
May 5, 2021
Testosterone Cypionate 200 Milligram/Milliliter Injectable Solution
Subjects in one arm will be randomized to receive testosterone cypionate 200 mg/ml intramuscularly every 4 weeks for a total of three doses after visit 1, and receive placebo injectable saline for the same duration starting at visit 2. Subjects in the other arm will be randomized to receive placebo injectable saline every 4 weeks for a total of 3 doses after visit 1, and testosterone cypionate 200 mg/ml intramuscularly for the same duration starting at visit 2.
Placebo injectable saline
Subjects in one arm will be randomized to receive testosterone cypionate 200 mg/ml intramuscularly every 4 weeks for a total of three doses after visit 1, and receive placebo injectable saline for the same duration starting at visit 2. Subjects in the other arm will be randomized to receive placebo injectable saline every 4 weeks for a total of 3 doses after visit 1, and testosterone cypionate 200 mg/ml intramuscularly for the same duration starting at visit 2.
Children's Hospital Colorado, Aurora
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Colorado, Denver
OTHER